痴呆的精神行为症状.ppt

  1. 1、本文档共44页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Psychiatric symptoms were improved more by secondgeneration antipsychotic drugs than by placebo in 421 outpatients with Alzheimer’s disease who had psychotic symptoms or agitation. For patients who completed 12 weeks of treatment witholanzapine奥氮平, quetiapine喹硫平, or risperidone利培酮, the proportions who were “much” or “very much” improved were 45%, 52%, and 61%, compared to 40% who were improved with placebo. Sultzer et al (CME, p. 844) found that treatment effects in the Clinical Antipsychotic Trials of Intervention Effectiveness—Alzheimer’s Disease (CATIEAD) varied among the antipsychotics and specific symptoms. The effect on hostility—including anger, aggression, and paranoia—was most notable. None of the drugs, however, improved cognition, depression, functional abilities, care needs, or quality of life. Dr. Susan Schultz reviews these CATIE-AD results in an editorial on p. 787. Key Point: Mild behavioural problems can be managed with non-pharmacologic methods Non-pharmacologic interventions aim to: Address the underlying and unmet needs that are causing the inappropriate behaviour Change the relationship between antecedents, behaviour and reinforcement Reduce the stimulation levels that may result in overreaction in the cognitively impaired person References Cohen-Mansfield J. Assessment of disruptive behaviour/agitation in the elderly: function, methods, and difficulties. J Geriatr Psychiatry Neurol. 1995;8(1):52-60. Caltagirone C et al. Drugs Aging. 2005;22(Suppl 1):1-26. 国内多中心研究 (孙新宇, 于欣,等. 中华精神科杂志, 2004) 国内多中心研究 (孙新宇, 于欣,等. 中华精神科杂志, 2004) 护养院中喹硫平治疗认知功能下降 40 20 0 -20 -40 -60 安慰剂 卡巴拉汀 喹硫平 与基线相比SIB分数的变化 * *6周治疗时间 恶化 改善 Ballard C, et al. BMJ 2005;330:874 非典型抗精神病药物的使用 Add your title in here 体重增加 糖尿病 (血糖升高) 帕金森综合征 迟发性运动障碍:传统抗精神病药物引起TD,造成运动功能障碍 嗜睡 奥氮平(1.3%)vs 安慰剂(0.4%) 脑血管事件 利培酮(1.3%)vs 安慰剂(0.6%) “‘适应症外’使用‘非典型抗精神病药物’治疗老年痴呆患者行为障碍的临床研究显示,与使用安慰剂治疗的患者相比,非典型抗精神病药物治疗相关的死亡率高1.6-1.7倍 。” 绝对危险未报道。 FDA关于抗精神病药物用于 老年患者行为障碍治疗的建议 /bbs/topics/ANSWERS/2005/

文档评论(0)

nuvem + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档